Food and Drug Administration (FDA)

News

Genetically Modified Food Labeling Measure to Qualify for Washington State Ballot

News

US FDA New Drug Approvals Hit 16-Year High in 2012

News

FDA Approves Bristol Myers, Pfizer's Anti-Clotting Drug Eliquis

News

Number of New Drugs Picks Up in Europe and U.S.

News

U.S. Supreme Court to Review Lawsuits over Flaws in Generic Drugs

News

Ranbaxy Halts Generic Lipitor Production After Recall

News

India's Ranbaxy Recalls Generic Lipitor in U.S.

News

Roche Offers Compromise in Flu Drug Row

News

Social Media in Pharmaceutical Companies

News

Novartis CEO Says U.S. Plant Gets FDA Clearance

News

Drugmaker Boehringer Settles Marketing Claim for $95 Million

News

ThromboGenics Says Main Drug Cleared for U.S. Launch

News

FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

News

How Compounding Pharmacies Rallied Patients to Fight Regulation

News

U.S. FDA Cracks Down on Thousands of Websites for Selling Fake Drugs

News

U.S. Finds No Wrongdoing in Yasmin Patent Settlement

News

Atox Bio to Seek Funds by Year-End for More Trials

News

FDA Approves Teva Version of Amgen's Neupogen

News

Watson Sues FDA on Generic Diabetes Drug Ruling

50 more articles

Top-Feature

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

INOSIM GmbH

Predictive Simulation in Pharma Production

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Food and Drug Administration (FDA)

Top-Feature

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

Siemens Joins the Global Impact Coalition

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Newsletter & e-edition